The Indian pharmaceutical market (IPM) registered a 6.1 per cent value growth in October 2024, with major therapies showing ...

As a reminder, Acadia Pharmaceuticals has two primary products on the market. The first is Nuplazid, which was approved in ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

With the rise in global counterfeiting operations, stakeholders need to be aware of their responsibility when it comes to pharmaceutical goods and their legitimacy. Companies can make this task easier ...

The Danish firm’s patents for semaglutide, the active pharmaceutical ingredient in its star brands, will start expiring in ...

Dr Reddy's Laboratories is aiming to move up to the fifth rank in the Indian pharma market within the next five years, the ...

WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

Royalty Pharma's Q3 results show growth driven by strong portfolio performance and acquisitions. See why we recommend a buy ...

On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its ...

Sun Pharmaceutical Industries Ltd, India’s largest drugmaker, has long been a favourite among investors. However, recent challenges, including a market-wide sell-off and a setback in its ...

For market entry strategy for drugs in Japan, understanding the submission requirements is as crucial as the documentation itself. The submission dossier must be meticulously prepared, containing all ...